Skip to main content

Advertisement

Log in

Increased level of platelet P-selectin in nonarteritic anterior ischemic optic neuropathy

  • Neurophthalmology
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

P-selectin receptor is expressed in platelets and endothelial cells in a cell-activation-dependent manner. Platelet P-selectin (CD62) levels may become elevated in a number of vasoocclusive diseases, including arteriosclerosis, atherothrombosis, and diabetes mellitus (DM). Nonarteritic anterior ischemic optic neuropathy (NAION) is associated with a sudden loss of vision due to the vascular insufficiency of ciliary arteries supplying the optic nerve. In this study, our aim was to investigate the presence of increased platelet reactivity in the development of NAION.

Methods

Twenty-one NAION patients, 39 healthy control subjects, and 44 patients suffering from diabetes mellitus (DM) were examined in our case-control, pilot study. Platelet activation was investigated by flow cytometric analysis of the mean fluorescence intensity (MFI) of CD62 on platelets. These results were compared among the different study groups.

Results

NAION patients showed considerably although not signifactly (p = 0.2017) higher P-selectin MFI values (71.98 ± 40.30) versus healthy subjects (55.48 ± 20.95), insulin-dependent DM patients (50.02 ± 13.08), and non-insulin-dependent DM subjects (54.72 ± 24.74). However, logistic regression analysis resulted in a statistically significant adjusted effect on the odds of NAION when CD62 MFI values were logarithmically transformed (OR: 3.86, 95 % CI: 1.10 to 13.53, p = 0.0346).

Conclusion

Elevated platelet CD62 positivity may be related to NAION, suggesting a possible role of enlarged platelet activity in the generation of this type of ischemic optic neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kappelmayer J, Nagy B Jr, Miszti-Blasius K, Hevessy Z, Setiadi H (2004) The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 42:475–486

    Article  PubMed  CAS  Google Scholar 

  2. Furie B, Furie BC (2004) Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 10:171–178

    Article  PubMed  CAS  Google Scholar 

  3. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD (2000) Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 97:13835–13840

    Article  PubMed  CAS  Google Scholar 

  4. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR (1996) In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 93:11877–11882

    Article  PubMed  CAS  Google Scholar 

  5. Amrani DL, Stojanovic L, Mosesson MN, Shalev Y, Mosesson MW (1995) Development of a whole platelet ELISA to detect circulating activated platelets. J Lab Clin Med 126:603–611

    PubMed  CAS  Google Scholar 

  6. Minamino T, Kitakaze M, Asanuma H, Ueda Y, Koretsune Y, Kuzuya T, Hori M (1999) Plasma adenosine levels and platelet activation in patients with atrial fibrillation. Am J Cardiol 83:194–198

    Article  PubMed  CAS  Google Scholar 

  7. Nagy B Jr, Csongradi E, Bhattoa HP, Balogh I, Blasko G, Paragh G, Kappelmayer J, Kaplar M (2007) Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thromb Haemost 98:186–191

    PubMed  CAS  Google Scholar 

  8. Marquardt L, Ruf A, Mansmann U, Winter R, Schuler M, Buggle F, Mayer H, Grau AJ (2002) Course of platelet activation markers after ischemic stroke. Stroke 33:2570–2574

    Article  PubMed  CAS  Google Scholar 

  9. Burger PC, Wagner DD (2003) Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101:2661–2666

    Article  PubMed  CAS  Google Scholar 

  10. Jilma B, Fasching P, Ruthner C, Rumplmayr A, Ruzicka S, Kapiotis S, Wagner OF, Eichler HG (1996) Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 76:328–332

    PubMed  CAS  Google Scholar 

  11. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN (1994) Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 83:1535–1541

    PubMed  CAS  Google Scholar 

  12. Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Watanabe K, Ikeda Y (1993) Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol 84:702–710

    Article  PubMed  CAS  Google Scholar 

  13. Chung I, Choudhury A, Patel J, Lip GY (2009) Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure. Ann Med 41:45–51

    Article  PubMed  CAS  Google Scholar 

  14. Nagy V, Facsko A, Takacs L, Balazs E, Berta A, Balogh I, Edes I, Czuriga I, Pfliegler G (2004) Activated protein C resistance in anterior ischaemic optic neuropathy. Acta Ophthalmol Scand 82:140–143

    Article  PubMed  CAS  Google Scholar 

  15. Nagy V, Steiber Z, Takacs L, Vereb G, Berta A, Bereczky Z, Pfliegler G (2006) Trombophilic screening for nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 244:3–8

    Article  PubMed  Google Scholar 

  16. Hayreh SS (1974) Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis. Br J Ophthalmol 58:955–963

    Article  PubMed  CAS  Google Scholar 

  17. Hayreh SS, Joos KM, Podhajsky PA, Long CR (1994) Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118:766–780

    PubMed  CAS  Google Scholar 

  18. Hayreh SS, Podhajsky PA, Zimmerman B (1997) Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 124:641–647

    PubMed  CAS  Google Scholar 

  19. Beck RW, Servais GE, Hayreh SS (1987) Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 94:1503–1508

    PubMed  CAS  Google Scholar 

  20. Beri M, Klugman MR, Kohler JA, Hayreh SS (1987) Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology 94:1020–1028

    PubMed  CAS  Google Scholar 

  21. Mojon DS, Hedges TR 3rd, Ehrenberg B, Karam EZ, Goldblum D, Abou-Chebl A, Gugger M, Mathis J (2002) Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 120:601–605

    PubMed  Google Scholar 

  22. Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N, Yassur I, Vidne O, Zivelin A, Gitel S, Davidson J, Ravid B, Seligsohn U (1999) Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 106:739–742

    Article  PubMed  CAS  Google Scholar 

  23. Salomon O, Rosenberg N, Steinberg DM, Huna-Baron R, Moisseiev J, Dardik R, Goldan O, Kurtz S, Ifrah A, Seligsohn U (2004) Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene. Ophthalmology 111:184–188

    Article  PubMed  Google Scholar 

  24. Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509–520

    Article  PubMed  CAS  Google Scholar 

  25. Hollander JE, Muttreja MR, Dalesandro MR, Shofer FS (1999) Risk stratification of emergency department patients with acute coronary syndromes using P-selectin. J Am Coll Cardiol 34:95–105

    Article  PubMed  CAS  Google Scholar 

  26. Robless PA, Okonko D, Lintott P, Mansfield AO, Mikhailidis DP, Stansby GP (2003) Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg 25:16–22

    Article  PubMed  CAS  Google Scholar 

  27. Weikert U, Kuhl U, Schultheiss HP, Rauch U (2002) Platelet activation is increased in patients with cardiomyopathy: myocardial inflammation and platelet reactivity. Platelets 13:487–491

    Article  PubMed  CAS  Google Scholar 

  28. Zeiger F, Stephan S, Hoheisel G, Pfeiffer D, Ruehlmann C, Koksch M (2000) P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis 11:723–728

    Article  PubMed  CAS  Google Scholar 

  29. Body R, Pemberton P, Ali F, McDowell G, Carley S, Smith A, Mackway-Jones K (2011) Low soluble P-selectin may facilitate early exclusion of acute myocardial infarction. Clin Chim Acta 412:614–618

    Article  PubMed  CAS  Google Scholar 

  30. Grau AJ, Ruf A, Vogt A, Lichy C, Buggle F, Patscheke H, Hacke W (1998) Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost 80:298–301

    PubMed  CAS  Google Scholar 

  31. Zeller JA, Tschoepe D, Kessler C (1999) Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb Haemost 81:373–377

    PubMed  CAS  Google Scholar 

  32. Turkoz Y, Evereklioglu C, Ozkiris A, Mistik S, Borlu M, Ozerol IH, Duygulu F, Ilhan O (2005) Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behcet’s syndrome. Mediat Inflamm 2005:237–241

    Article  Google Scholar 

  33. Kupersmith MJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C, Warren FA (1997) Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol 17:250–253

    Article  PubMed  CAS  Google Scholar 

  34. Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, Dickersin K, Ischemic Optic Neuropathy Decompression Trial Research Group (2002) The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 134:317–328

    Article  PubMed  Google Scholar 

  35. Atkins EJ, Bruce BB, Newman NJ, Biousse V (2010) Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol 55:47–63

    Article  PubMed  Google Scholar 

  36. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S (2003) Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73:232–241

    Article  PubMed  CAS  Google Scholar 

  37. Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, Meyer BJ (2000) Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol 36:699–705

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valeria Nagy.

Additional information

Valeria Nagy and Bence Kolozsvari equally contributed to this paper as first authors.

The authors have no conflict of interest in this study. This paper has not been published or submitted for publication elsewhere.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagy, V., Kolozsvari, B., Balogh, Z. et al. Increased level of platelet P-selectin in nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 251, 917–922 (2013). https://doi.org/10.1007/s00417-012-2196-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-012-2196-0

Keywords

Navigation